Market News How it works Learn FAQ
| AXG 0.04 -25.65% | SHFS 0.1158 23.19% | DVLT 0.067 -49.55% | XXII 0.1048 18.55% | NEXR 0.5454 21.77% | SOFI 16.4 13.42% | WFF 0.0601 -33.07% | NU 12.4 -1.51% | NVD 3.93 -1.50% | SPCX 148.58 1.14% | SOXL 101.08 11.69% | EWZ 34.3 0.45% | INTC 93.74 3.61% | NVDA 217.94 0.90% | BBD 2.91 -0.51% | SOXS 42.5 -11.42% | GPUS 0.2126 19.10% | JBLU 2.82 18.99% | GRAB 2.72 0.37% | NOK 8.89 3.30% | VALE 11.84 -1.33% | SNTI 0.1867 6.62% | AAL 12.61 3.36% | HYG 77.6 0.52% | BITO 10.79 1.27% | CRWV 59.57 7.94% | TSLL 11.63 8.09% | RCT 0.0656 -20.68% | META 620.19 -1.64% | TQQQ 71.04 3.81% | QID 13.86 -2.53% | STLA 4.14 1.47% | NFLX 62.52 -2.16% | TSLG 5.82 8.18% | ONDS 6.65 7.95% | BA 168.18 -10.69% | IREN 27.44 7.90% | T 20.94 0.46% | BRAI 3.31 56.13% | PLUG 1.4 2.19% | TSLA 407.46 4.04% | CIFR 8.48 9.99% | RIG 6.46 -1.07% | F 11.71 1.12% | RWM 14.34 -1.10% | XP 15.96 1.62% | KORU 11.86 8.91% | AAPL 347.1 0.93% | ITUB 7.67 -0.39% | SNAP 6.06 -4.42%
CCCryo-Cell International, Inc. logo

Cryo-Cell International, Inc. (CCEL)

New York Stock Exchange Arca · Currency in USD
$4.96 ▼ -0.05 (-1.00%)
At close: Oct 27, 4:00 PM ET. Market closed.

Summary

Previous Close
$5.01
Open
$4.97
Day's Range
$4.83 – $5.00
52 Week Range
$2.72 – $5.20
Volume
3,268
Avg. Volume
21,048
Market Cap
$39.99M
Beta (5Y Monthly)
0.59
PE Ratio (TTM)
--
EPS (TTM)
-$0.35
Earnings Date
Feb 26, 2027
Forward Dividend & Yield
$0.60 (12.10%)
Ex-Dividend Date
May 21, 2025
1y Target Est
$8.50

Profile: Cryo-Cell International, Inc.

Sector
Healthcare
Industry
Medical - Care Facilities
Full-time employees
74
CEO
David Portnoy

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells.

Earnings

Next report: Fri, Feb 26, 2027
EPS estimate $0.05 · Revenue est. $7.35M
DateEst.Actual
Oct 9, 2026$0.03$0.16Beat
Jul 15, 2026-$0.02$0.07Beat
Apr 14, 2026-$0.02$0.01Beat
Feb 27, 2026-$0.09-$0.47Miss
Oct 15, 2025–$0.09
Jul 15, 2025-$0.03$0.04Beat

Analyst view

Consensus price target
$8.50 ▲ +71.4%
Range $8.50 – $8.50
Rating: Hold
Buy 0% · Hold 100% · Sell 0%

Get free alerts on CCEL and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.